Anti-GCGR treatment effectively reverses hyperglycemia, elevates plasma insulin levels, and restores β-cell mass through both β-cell proliferation and α-to-β-cell transdifferentiation [13,14,15,16]. The gene discussed is INS; the disease is Hyperglycemia.